Jagged-directed therapy in multiple myeloma: a new approach to interrupt the crosstalk between the tumor cell and the bone marrow microenvironment
M. Colombo(Human Technopole), Raffaella Chiaramonte(University of Milan), Katia Todoerti(Fondazione IRCCS Istituto Nazionale dei Tumori), R. Colella(University of Milan), Carl S. Goodyear(University of Glasgow), Catriona Jamieson(La Jolla Alcohol Research), Katja Thümmler(Institute of Infection and Immunity), S. Garavelli(University of Milan), Antonino Neri(University of Milan), F. Baccianti(German Cancer Research Center), Elisa Lazzari(University of Trieste), Maria Teresa Palano(University of Milan), S. Galletti, Natalia Platonova(University of Milan), Leslie Crews(University of California San Diego)
Unknown
November 5, 2017
Cited by 0
Related Papers
Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML
|New England Journal of Medicine|2004|1.5k
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Molecular mechanisms of neurodegeneration in Alzheimer's disease
|Human Molecular Genetics|2010|760
Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
|PLoS ONE|2010|369
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
|European Journal of Immunology|2012|304